Project Heparegenix – Synthese und Charakterisierung niedermolekularer Inhibitoren der Proteinkinase MKK4

Basic data

Acronym:
Heparegenix
Title:
Synthese und Charakterisierung niedermolekularer Inhibitoren der Proteinkinase MKK4
Duration:
01/01/2020 to 31/12/2021
Abstract / short description:
siehe Vorläuferprojekt, hier handelt es sich nur um eine Verlängerung

Involved staff

Managers

Faculty of Science
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Local organizational units

Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science

Funders

Ulm, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.